Compositions and methods for immune cell modulation in adoptive immunotherapies
US12036241B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 19, 2018 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Apr 23, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that either produce a higher proportion or greater absolute number of phenotypically identified naive, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including T, NK, and NKT cells for adoptive cell therapies, such as those providing improvements in one or more therapeutic outcomes, are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.